The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...

An Alzheimer's drug deemed the "best ever" is set to be blocked for NHS use due to its high cost. Donanemab, manufactured by ...

NHS patients are set to miss out on new Alzheimer’s drugs, experts warn ...

A SECOND “game-changing” Alzheimer’s drug shown to slow the progression of the disease has been approved in the UK. Donanemab, developed by pharmaceutical giant Eli Lilly, was ...

The treatment – one of two new drugs to target a cause of the disease – has been considered by the medicines regulator and the NHS spending watchdog. A decision is expected imminently. Donanemab, ...

Eli Lilly invests £279M in the UK to boost life sciences, while its Alzheimer's drug, donanemab, faces European regulatory ...

A blood test that detects Alzheimer’s up to 15 years before symptoms emerge is set to be made free on the NHS within a year. The new test is cheaper, easier and at least as accurate as the ...

SCOTLAND has a “golden opportunity” to lead the way in dementia care if the NHS is given the go-ahead to use a new kind of treatment. That’s the prediction of ­Henry ­Simmons, chief executive of ...

Amid the excitement around new investments, scrutiny continues over Lilly's Alzheimer's drug ... ruled the drug too costly for NHS prescriptions.